Approvals/TGA/ZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack

Approved

STANDARD

ZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack

Bristol-Myers Squibb Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: d685c323d2054dec
Product Name: ZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack
Artg Id: 318801
Artg Name: ZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack
Sponsor: Bristol-Myers Squibb Australia Pty Ltd
Company Detail Path: /organization/bristol-myers-squibb-australia-pty-ltd
Artg Date: 2020-07-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/b2ca4fc00220d3fa6d872e78c07129cd.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/cbf3e4c40a7b85cf63b976e2405227d6.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

d685c323d2054dec

Type

Standard